[Chinese Expert Consensus on Next Generation Sequencing Diagnosis for Non-small Cell Lung Cancer (2020 Edition)]
- PMID: 32957170
- PMCID: PMC7519957
- DOI: 10.3779/j.issn.1009-3419.2020.101.45
[Chinese Expert Consensus on Next Generation Sequencing Diagnosis for Non-small Cell Lung Cancer (2020 Edition)]
Abstract
【中文题目:二代测序技术在NSCLC中的临床应用 中国专家共识(2020版)】.
Similar articles
-
[Chinese Expert Consensus on Antiangiogenic Drugs for Advanced Non-small Cell Lung Cancer (2019 Edition)].Zhongguo Fei Ai Za Zhi. 2019 Jul 20;22(7):401-412. doi: 10.3779/j.issn.1009-3419.2019.07.01. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31315778 Free PMC article. Chinese.
-
[Expert Consensus on Adjuvant Therapy of Non-small Cell Lung Cancer from China Thoracic Surgeons (2018 Version)].Zhongguo Fei Ai Za Zhi. 2018 Oct 20;21(10):731-737. doi: 10.3779/j.issn.1009-3419.2018.10.01. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30309423 Free PMC article. Chinese.
-
Should Interventional Pulmonologists Take Ownership for Ordering Next-Generation Sequencing and Immunohistochemistries for Patients With Newly Diagnosed Non-Small Cell Lung Cancer?Chest. 2019 Dec;156(6):1281-1282. doi: 10.1016/j.chest.2019.06.044. Chest. 2019. PMID: 31812206 No abstract available.
-
Staging and the surgical management of lung cancer.Radiol Clin North Am. 2000 May;38(3):545-61, ix. doi: 10.1016/s0033-8389(05)70184-6. Radiol Clin North Am. 2000. PMID: 10855261 Review.
-
[Recommendations for surgical treatment of nonsmall cell lung cancer].Pneumologia. 2009 Apr-Jun;58(2):135-40. Pneumologia. 2009. PMID: 19637769 Review. Romanian.
Cited by
-
Protocol of an iterative qualitative study to develop a molecular testing decision aid for shared decision-making in patients with lung cancer after surgery.BMJ Open. 2022 Sep 19;12(9):e061367. doi: 10.1136/bmjopen-2022-061367. BMJ Open. 2022. PMID: 36123064 Free PMC article.
-
Consensus Statements on Precision Oncology in the China Greater Bay Area.JCO Precis Oncol. 2023 Jun;7:e2200649. doi: 10.1200/PO.22.00649. JCO Precis Oncol. 2023. PMID: 37315266 Free PMC article.
-
[Advances in Treatment of Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations].Zhongguo Fei Ai Za Zhi. 2022 May 20;25(5):337-350. doi: 10.3779/j.issn.1009-3419.2022.103.01. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35599009 Free PMC article. Review. Chinese.
-
[Progress in Detection of EGFR Exon 20 Insertion Mutation and Targeted Therapies in Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi. 2023 Feb 20;26(2):135-147. doi: 10.3779/j.issn.1009-3419.2023.102.06. Zhongguo Fei Ai Za Zhi. 2023. PMID: 36872052 Free PMC article. Review. Chinese.
-
Concordance of Abundance for Mutational EGFR and Co-Mutational TP53 with Efficacy of EGFR-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer.Curr Oncol. 2023 Sep 15;30(9):8464-8476. doi: 10.3390/curroncol30090616. Curr Oncol. 2023. PMID: 37754531 Free PMC article.
References
-
-
Globocan 2018 (IARC), Available from: http://gco.iarc.fr/. Accessed August 31, 2020.
-
-
- Chinese Medical Association, Oncology Society of Chinese Medical Association, Chinese Medical Association Publishing House Chinese medical association guidelines for clinical diagnosis and treatment of lung cancer (Edition 2018) Zhong Liu Yan Jiu Yu Lin Chuang. 2018;30(12):793–824. - PubMed
- 中华医学会, 中华医学会肿瘤学分会, 中华医学会杂志社 中华医学会肺癌临床诊疗指南(2018版) 肿瘤研究与临床. 2018;30(12):793–824. doi: 10.3760/cma.j.issn.1006-9801.2018.12.001. - DOI
-
-
Surveillance, Epidemiology, and End Results (SEER) Program; National Cancer Institute. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), Updated August 20, 2012. Lung and Bronchus. Available from: http://seer.cancer.gov/csr/1975_2009_pops09/results_merged/sect_15_lung_bronchus.pdf. Accessed August 31, 2020.
-
-
-
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: non-small cell lung cancer, Version 6. 2020. Available from: http://www.nccn.org/default.aspx. Accessed August 31, 2020.
-
MeSH terms
LinkOut - more resources
Full Text Sources
Medical